Guangjun Nie Selected Research

ErbB Receptors (EGF Receptor)

11/2018	Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 ( BRCA2) Mutation.
4/2016	Cancer Cell-derived Exosomes Induce Mitogen-activated Protein Kinase-dependent Monocyte Survival by Transport of Functional Receptor Tyrosine Kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangjun Nie Research Topics

Disease

115	Neoplasms (Cancer) 12/2022 - 01/2002
16	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2014
14	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2014
13	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 04/2015
6	Melanoma (Melanoma, Malignant) 05/2022 - 09/2012
5	Iron Overload 03/2022 - 01/2015
4	Infarction (Infarctions) 07/2021 - 10/2018
4	Thrombosis (Thrombus) 01/2020 - 01/2018
4	Inflammation (Inflammations) 12/2019 - 07/2013
4	Fibrosis (Cirrhosis) 12/2019 - 10/2013
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2002
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2016
3	Adenocarcinoma 01/2021 - 01/2018
3	Hypoxia (Hypoxemia) 01/2021 - 01/2019
3	Iron Deficiencies 03/2020 - 03/2005
3	Infections 05/2019 - 01/2014
3	Necrosis 01/2019 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 08/2017 - 01/2011
3	Triple Negative Breast Neoplasms 01/2017 - 02/2015
2	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2019
2	Splenomegaly 12/2020 - 10/2020
2	Lymphadenopathy 12/2020 - 10/2020
2	Starvation 11/2020 - 10/2006
2	Hemorrhage 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

38	Pharmaceutical PreparationsIBA 07/2022 - 10/2010
24	Peptides (Polypeptides)IBA 01/2021 - 01/2011
19	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2012
16	IronIBA 03/2022 - 10/2006
9	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2022 - 11/2011
9	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2018
9	VaccinesIBA 01/2022 - 09/2012
8	Gemcitabine FDA Link 01/2022 - 04/2015
8	Small Interfering RNA (siRNA)IBA 01/2022 - 02/2015
8	AntigensIBA 01/2022 - 02/2019
8	GoldIBA 12/2019 - 04/2013
8	Ferritins (Ferritin)IBA 10/2019 - 03/2005
7	Liposomes (Liposome)IBA 11/2021 - 02/2016
6	Transferrin Receptors (Transferrin Receptor)IBA 03/2022 - 03/2005
6	PolymersIBA 01/2022 - 10/2010
5	LipidsIBA 01/2022 - 04/2015
5	Thromboplastin (Tissue Factor)IBA 07/2021 - 09/2015
5	Biological ProductsIBA 01/2021 - 10/2012
5	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 07/2014
5	Thrombin FDA Link 01/2020 - 01/2018
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 10/2012
5	HepcidinsIBA 04/2017 - 07/2014
4	Chelating AgentsIBA 03/2022 - 12/2018
4	Angiogenesis InhibitorsIBA 01/2022 - 01/2019
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 02/2019
4	RNA (Ribonucleic Acid)IBA 10/2021 - 03/2005
4	A-Form DNA (A-DNA)IBA 03/2021 - 01/2018
4	Fibronectins (Fibronectin)IBA 01/2021 - 01/2019
4	CytokinesIBA 01/2021 - 12/2018
4	Glutathione (Reduced Glutathione)IBA 01/2020 - 06/2018
4	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 01/2020 - 01/2017
3	pHLIP proteinIBA 12/2022 - 02/2018
3	Messenger RNA (mRNA)IBA 05/2022 - 01/2018
3	LigandsIBA 03/2022 - 02/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	NanovaccinesIBA 10/2021 - 01/2021
3	Cancer VaccinesIBA 05/2021 - 09/2012
3	Therapeutic UsesIBA 01/2021 - 12/2015
3	PlatinumIBA 01/2020 - 06/2018
3	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2018
3	FibrinIBA 01/2020 - 01/2019
3	AntioxidantsIBA 06/2018 - 01/2002
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 12/2014
3	Amyloid (Amyloid Fibrils)IBA 08/2017 - 01/2011
3	Oxidopamine (6 Hydroxydopamine)IBA 09/2010 - 01/2002
2	ThioredoxinsIBA 12/2022 - 02/2018
2	mRNA VaccinesIBA 05/2022 - 10/2021
2	graphene oxideIBA 10/2021 - 12/2014
2	HydrogelsIBA 10/2021 - 02/2018
2	NucleolinIBA 07/2021 - 01/2018
2	polydopamineIBA 01/2021 - 01/2017
2	Beclin-1IBA 10/2020 - 02/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020 - 06/2018
2	IonsIBA 08/2020 - 01/2020
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2020 - 01/2019
2	MetalsIBA 01/2020 - 12/2005
2	SolutionsIBA 01/2020 - 04/2019
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2019 - 10/2013
2	AngiopoietinsIBA 09/2019 - 01/2019
2	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2019 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2019 - 11/2014
2	polyethylene glycol polyethyleneimine nanogelIBA 01/2019 - 04/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2010
2	TicagrelorIBA 01/2019 - 01/2017
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2018 - 04/2016
2	Phosphotransferases (Kinase)IBA 03/2018 - 04/2016

Therapy/Procedure

54	Therapeutics 12/2022 - 11/2011
20	Drug Therapy (Chemotherapy) 07/2022 - 10/2012
12	Immunotherapy 01/2022 - 09/2012
6	Photothermal Therapy 01/2022 - 11/2014
5	Lasers (Laser) 01/2017 - 11/2014
4	Intravenous Injections 12/2022 - 02/2018
3	Radiotherapy 01/2022 - 01/2018
2	Photochemotherapy (Photodynamic Therapy) 04/2019 - 11/2014
2	Precision Medicine 01/2019 - 02/2015